Skip to main content
Equibles

Blue Owl Capital Holdings LP

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1858703 New York, NY
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,098,282
-$241,984 QoQ
Shares Held
182,638
-39.7% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
#74
of 311 holders
Holding Since
Dec 2023
11 quarters on record

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blue Owl Capital Holdings LP holds $278,984,828 across 30 Biotechnology names. RARE ranks #11 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AKTS
Aktis Oncology, Inc.
 3,070,219 $98,953,158
2 CGEM
Cullinan Therapeutics, Inc.
 1,539,764 $28,039,102
3 LRMR
Larimar Therapeutics, Inc.
 9,163,157 $27,947,628
4 MPLT
MapLight Therapeutics, Inc.
 729,929 $26,160,655
5 EYPT
EyePoint, Inc.
 762,594 $10,905,094
6 SGMT
Sagimet Biosciences Inc.
 1,260,544 $9,744,005
7 CRVS
Corvus Pharmaceuticals, Inc.
 608,600 $9,092,484
8 ARTV
Artiva Biotherapeutics, Inc.
 874,542 $8,483,057

All Filings in RARE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,098,282 182,638
2026-03-31 $6,340,266 302,638
2025-12-31 $4,890,674 212,638
2025-09-30 $12,706,935 422,438
2025-06-30 $9,280,453 255,238
2025-03-31 $5,548,747 153,238
2024-12-31 $4,974,272 118,238
2024-09-30 $9,067,870 163,238
2024-06-30 $11,024,581 268,238
2024-03-31 $12,524,032 268,238
2023-12-31 $12,588,041 263,238